Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Control of apoptosis by Rel/NF-kappaB transcription factors.
|
Oncogene
|
1999
|
4.76
|
2
|
Mutations in the NF-kappaB signaling pathway: implications for human disease.
|
Oncogene
|
2006
|
3.49
|
3
|
Good cop, bad cop: the different faces of NF-kappaB.
|
Cell Death Differ
|
2006
|
3.04
|
4
|
vRel is an inactive member of the Rel family of transcriptional activating proteins.
|
J Virol
|
1991
|
2.04
|
5
|
Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T.
|
Cell
|
1986
|
1.96
|
6
|
Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
|
Proc Natl Acad Sci U S A
|
1998
|
1.81
|
7
|
Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.
|
Oncogene
|
1990
|
1.80
|
8
|
Tyrosine phosphorylation of a 50K cellular polypeptide associated with the Rous sarcoma virus transforming protein pp60src.
|
Mol Cell Biol
|
1982
|
1.49
|
9
|
The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.
|
Nucleic Acids Res
|
1992
|
1.36
|
10
|
LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains.
|
Biochim Biophys Acta
|
2001
|
1.33
|
11
|
A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.
|
Mol Cell Biol
|
1991
|
1.29
|
12
|
Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro.
|
J Biol Chem
|
1997
|
1.25
|
13
|
Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
|
Oncogene
|
1999
|
1.24
|
14
|
p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
|
J Virol
|
1992
|
1.24
|
15
|
Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1.
|
J Virol
|
1994
|
1.12
|
16
|
v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
|
Oncogene
|
1993
|
1.07
|
17
|
The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells.
|
Oncogene
|
1995
|
1.06
|
18
|
Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
|
Oncogene
|
1993
|
1.03
|
19
|
Characterization of mouse Trip6: a putative intracellular signaling protein.
|
Gene
|
1999
|
0.99
|
20
|
Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
|
Oncogene
|
1991
|
0.99
|
21
|
Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
|
Oncogene
|
2006
|
0.97
|
22
|
Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.
|
Oncogene
|
2009
|
0.97
|
23
|
The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
|
Oncogene
|
1993
|
0.96
|
24
|
Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
|
Oncogene
|
1996
|
0.94
|
25
|
AAT1, a gene encoding a mitochondrial aspartate aminotransferase in Saccharomyces cerevisiae.
|
Biochim Biophys Acta
|
1992
|
0.92
|
26
|
LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor.
|
Gene Expr
|
1999
|
0.92
|
27
|
NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
|
J Virol
|
1993
|
0.92
|
28
|
Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
|
Cell Growth Differ
|
1995
|
0.91
|
29
|
The spleen necrosis virus int gene product expressed in Escherichia coli has DNA binding activity and mediates att and U5-specific DNA multimer formation in vitro.
|
Virology
|
1987
|
0.91
|
30
|
Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL.
|
Oncogene
|
2008
|
0.90
|
31
|
A conditional mutant of vRel containing sequences from the human estrogen receptor.
|
Virology
|
1993
|
0.88
|
32
|
Temperature-sensitive transforming mutants of the v-rel oncogene.
|
J Virol
|
1993
|
0.86
|
33
|
Total synthesis of the NF-kappa B inhibitor (-)-cycloepoxydon: utilization of tartrate-mediated nucleophilic epoxidation.
|
J Am Chem Soc
|
2001
|
0.85
|
34
|
Characterization of a chicken cDNA encoding the retinoblastoma gene product.
|
Biochim Biophys Acta
|
1994
|
0.84
|
35
|
GAL4-I kappa B alpha and GAL4-I kappa B gamma activate transcription by different mechanisms.
|
Nucleic Acids Res
|
1993
|
0.83
|
36
|
Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
|
Oncogene
|
2000
|
0.82
|
37
|
Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3.
|
Biochim Biophys Acta
|
2001
|
0.80
|
38
|
Clinically relevant findings.
|
J Clin Invest
|
1997
|
0.78
|
39
|
Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
|
Mol Cell Biol
|
1996
|
0.78
|
40
|
Transcription factors, oncogenes, and apoptosis.
|
Science
|
1997
|
0.76
|
41
|
Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
|
Oncogene
|
2000
|
0.76
|
42
|
The chicken RelB transcription factor has transactivation sequences and a tissue-specific expression pattern that are distinct from mammalian RelB.
|
Mol Cell Biol Res Commun
|
2001
|
0.75
|
43
|
Aseismic uplift in california.
|
Science
|
1981
|
0.75
|
44
|
In vitro-translated diphtheria toxin A chain inhibits translation in wheat germ extracts: analysis of biologically active, caspase-3-resistant diphtheria toxin mutants.
|
Biochim Biophys Acta
|
1999
|
0.75
|
45
|
Classroom performance and voice characteristics as measured by the contour sound spectrogram: preliminary report.
|
Psychol Rep
|
1970
|
0.75
|